FDA: No excess risk of asthma death from LABA/ICS inhalers; warnings removed
www.pulmccm.org
Combination inhalers for asthma and COPD containing long-acting beta agonists (LABA) drugs along with inhaled corticosteroids can lose their black-box warnings about their previously-theorized risk of asthma-related death, the FDA announced.
FDA: No excess risk of asthma death from LABA/ICS inhalers; warnings removed
FDA: No excess risk of asthma death from…
FDA: No excess risk of asthma death from LABA/ICS inhalers; warnings removed
Combination inhalers for asthma and COPD containing long-acting beta agonists (LABA) drugs along with inhaled corticosteroids can lose their black-box warnings about their previously-theorized risk of asthma-related death, the FDA announced.